EUVIMEDEUVIMED entdecken
Zurückgezogene PublikationOpen Access · CC BY 4.0

RETRACTED: Assessing the In Vitro and In Vivo Performance of L-Carnitine-Loaded Nanoparticles in Combating Obesity

Burcu Uner, Ahmet Dogan Ergin iD, Irfan Aamer Ansari iD, Melahat Sedanur Macit-Celebi iD, Siddique Akber Ansari iD, Hamad M Al Kahtani iD

Molecules · 16.10.2023 · 28 (20) · 7115

DOI: 10.3390/molecules28207115 ↗

Kurz gefasst

Zurückgezogene Publikation in der Zeitschrift Molecules, online erschienen am 16.10.2023. Verfasst von Burcu Uner und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Administrative and Pharmaceutical Sciences, University of Health Science and Pharmacy in St. Louis, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: Nanoparticles, Nanostructures. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Addressing obesity is a critical health concern of the century, necessitating urgent attention. L-carnitine (LC), an essential water-soluble compound, plays a pivotal role in lipid breakdown via β-oxidation and facilitates the transport of long-chain fatty acids across mitochondrial membranes. However, LC’s high hydrophilicity poses challenges to its diffusion through bilayers, resulting in limited bioavailability, a short half-life, and a lack of storage within the body, mandating frequent dosing. In our research, we developed LC-loaded nanoparticle lipid carriers (LC-NLCs) using economically viable and tissue-localized nanostructured lipid carriers (NLCs) to address these limitations. Employing the central composite design model, we optimized the formulation, employing the high-pressure homogenization (HPH) method and incorporating Poloxamer® 407 (surfactant), Compritol® 888 ATO (solid lipid), and oleic acid (liquid oil). A comprehensive assessment of nanoparticle physical attributes was performed, and an open-field test (OFT) was conducted on rats. We employed immunofluorescence assays targeting CRP and PPAR-γ, along with an in vivo rat study utilizing an isolated fat cell line to assess adipogenesis. The optimal formulation, with an average size of 76.4 ± 3.4 nm, was selected due to its significant efficacy in activating the PPAR-γ pathway. Our findings from the OFT revealed noteworthy impacts of LC-NLC formulations (0.1 mg/mL and 0.2 mg/mL) on adipocyte cells, surpassing regular L-carnitine formulations’ effects (0.1 mg/mL and 0.2 mg/mL) by 169.26% and 156.63%, respectively (p < 0.05).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesNanostructuresRatsAnimalsLipidsCarnitineDrug CarriersPeroxisome Proliferator-Activated ReceptorsParticle Size

Stichwörter der Autor:innen

NLCcarnitinecell cultureobesityopen-field test

Substanzen

LipidsCarnitineDrug CarriersPeroxisome Proliferator-Activated Receptors

Autor:innen und Institutionen

  • Department of Administrative and Pharmaceutical Sciences, University of Health Science and Pharmacy in St. Louis, St. Louis, MO 63110, USA.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy, Trakya University, 22030 Edirne, Turkey.
  • Department of Neuroscience, University of Turin, 10124 Turin, Italy.
  • Department of Pharmaceutical Nanotechnology, Institute of Health Sciences, Trakya University, 22030 Edirne, Turkey.
  • Department of Drug Science and Technology, University of Turin, 10124 Turin, Italy.
  • Department of Nutrition and Dietetics, Faculty of Health Sciences, Ondokuz Mayıs University, 55270 Samsun, Turkey.

ORCID-Profile: Ahmet Dogan Ergin, Irfan Aamer Ansari, Melahat Sedanur Macit-Celebi, Siddique Akber Ansari, Hamad M Al Kahtani

Förderung

  • King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Uner, B., Ergin, A. D., Ansari, I. A., Macit-Celebi, M. S., Ansari, S. A., & Kahtani, H. M. A. (2023). RETRACTED: Assessing the In Vitro and In Vivo Performance of L-Carnitine-Loaded Nanoparticles in Combating Obesity. Molecules, 28(20), 7115. https://doi.org/10.3390/molecules28207115

Vancouver

Uner B, Ergin AD, Ansari IA, Macit-Celebi MS, Ansari SA, Kahtani HMA. RETRACTED: Assessing the In Vitro and In Vivo Performance of L-Carnitine-Loaded Nanoparticles in Combating Obesity. Molecules. 2023;28(20):7115. doi:10.3390/molecules28207115

BibTeX
@article{Uner2023,
  author = {Uner, Burcu and Ergin, Ahmet Dogan and Ansari, Irfan Aamer and Macit-Celebi, Melahat Sedanur and Ansari, Siddique Akber and Kahtani, Hamad M Al},
  title = {RETRACTED: Assessing the In Vitro and In Vivo Performance of L-Carnitine-Loaded Nanoparticles in Combating Obesity},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {20},
  pages = {7115},
  doi = {10.3390/molecules28207115}
}
Kostenlos starten →